EGRX Short Information Eagle Pharmaceuticals Inc.

Twenty Trading Day Totals
Total Shorted Volume	416,879
Total Actual Volume	3,909,188

Averages
Average Short Volume	20,844
Average Short Percentage	50.13%

Is there a EGRX Short Squeeze or Breakout about to happen?

See the EGRX Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2022-09-27	27.49	27.83	27.92	27.17	162,817	18,732	52.5781
2022-09-26	26.95	27.1	28.28	26.95	131,612	13,756	54.5548
2022-09-23	26.82	26.99	27.27	26.58	150,867	18,341	55.9092
2022-09-22	26.87	27.13	27.52	26.21	102,996	12,376	58.7906
2022-09-21	27.64	26.88	28.1933	26.77	164,373	19,850	55.2956
2022-09-20	28.13	27.64	28.21	27.17	149,291	19,328	44.3771
2022-09-19	28.96	28.32	28.96	28.12	225,736	16,123	24.2952
2022-09-16	30.02	28.93	30.26	27.91	742,300	34,676	73.8164
2022-09-15	30.51	30.12	30.615	29.63	167,226	26,571	56.9240
2022-09-14	30.16	30.44	30.94	30.16	183,555	24,699	52.3073
2022-09-13	30.79	30.18	31.06	30.09	172,142	12,009	52.4456
2022-09-12	31.6	31.04	32.22	30.77	251,113	48,626	50.4948
2022-09-09	30.89	31.31	31.63	30.6	171,380	30,986	54.3223
2022-09-08	31.22	30.89	31.39	30.2	160,494	16,233	35.5371
2022-09-07	31.39	31.23	31.39	30.22	235,093	14,222	30.9174
2022-09-06	32.2	31.25	32.82	30.5	189,090	22,789	39.8897
2022-09-01	32.73	33.15	33.16	32.01	97,309	13,402	55.2500
2022-08-31	33.69	32.77	33.75	32.55	130,559	13,085	49.8514
2022-08-30	35.6	33.73	35.6	33.44	130,991	20,965	62.2513
2022-08-29	35.5	35.39	35.895	34.53	190,244	20,110	42.7472

Stock Information

Eagle Pharmaceuticals Inc. Company Name:

EGRX Stock Symbol:

NASDAQ Market:

Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

EGRX - Eagle Pharmaceuticals and Enalare Therapeutics Announce Additional Award Worth Up to $50 Million from BARDA to Advance an Intramuscular ("IM") Formulation of ENA-001

-- ENA-001, a new chemical entity with a unique mechanism of action, is being developed as an agnostic respiratory stimulant for use in multiple patient populations experiencing acute respiratory depression -- -- Development is under way of intramuscular formulation for treatment of c...
EGRX - Eagle Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

WOODCLIFF LAKE, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, President and Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the...
EGRX - Federal Circuit Rules in Favor of Eagle Pharmaceuticals in Vasopressin Litigation

WOODCLIFF LAKE, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the U.S. District Court for the District of Delaware ...